Published in Nucleic Acids Res on January 23, 2015
A newly identified berberine derivative induces cancer cell senescence by stabilizing endogenous G-quadruplexes and sparking a DNA damage response at the telomere region. Oncotarget (2015) 0.79
Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance. Nucleic Acids Res (2015) 0.78
Potassium increases the antitumor effects of ascorbic acid in breast cancer cell lines in vitro. Oncol Lett (2016) 0.75
Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev (2005) 15.19
A DNA damage checkpoint response in telomere-initiated senescence. Nature (2003) 12.55
How shelterin protects mammalian telomeres. Annu Rev Genet (2008) 11.20
DNA damage foci at dysfunctional telomeres. Curr Biol (2003) 9.08
Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature (2007) 6.82
Quantitative visualization of DNA G-quadruplex structures in human cells. Nat Chem (2013) 4.61
Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol (2010) 4.23
Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell (2006) 4.11
DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr Biol (2002) 3.95
The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell (2006) 3.45
Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol (2012) 3.03
Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol Cell (2005) 2.89
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene (1998) 2.56
Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nat Struct Mol Biol (2009) 2.08
The Apollo 5' exonuclease functions together with TRF2 to protect telomeres from DNA repair. Curr Biol (2006) 1.95
Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev (2003) 1.84
The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J (2010) 1.83
Transformation of human and murine fibroblasts without viral oncoproteins. Mol Cell Biol (2005) 1.81
The telomere deprotection response is functionally distinct from the genomic DNA damage response. Mol Cell (2013) 1.81
Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J (2009) 1.67
How shelterin solves the telomere end-protection problem. Cold Spring Harb Symp Quant Biol (2011) 1.51
Physiological relevance of telomeric G-quadruplex formation: a potential drug target. Bioessays (2007) 1.47
Five dysfunctional telomeres predict onset of senescence in human cells. EMBO Rep (2011) 1.45
Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest (2007) 1.39
Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration. Mol Pharmacol (2004) 1.37
Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway. Nucleic Acids Res (2009) 1.29
Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin Cancer Res (2007) 1.16
Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nat Cell Biol (2010) 1.14
A G-quadruplex structure within the 5'-UTR of TRF2 mRNA represses translation in human cells. Nucleic Acids Res (2010) 1.13
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nat Cell Biol (2013) 1.12
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. Biotechnol Adv (2011) 1.09
Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line. Cancer Res (2005) 1.07
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy. Oncogene (2010) 1.06
A three-state model of telomere control over human proliferative boundaries. Curr Opin Cell Biol (2012) 1.04
G-quadruplex structures in the human genome as novel therapeutic targets. Molecules (2013) 1.02
Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. J Med Chem (2002) 1.01
Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells. PLoS One (2010) 1.01
G-quadruplex interacting agents targeting the telomeric G-overhang are more than simple telomerase inhibitors. Curr Med Chem Anticancer Agents (2004) 0.97
Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma. Breast Cancer Res Treat (1999) 0.97
Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation. Blood (2011) 0.92
Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis. Nucleic Acids Res (2013) 0.90
DNA damage persistence as determinant of tumor sensitivity to the combination of Topo I inhibitors and telomere-targeting agents. Clin Cancer Res (2011) 0.88
Indoloquinolines as scaffolds for drug discovery. Curr Med Chem (2010) 0.86
Loss of telomere protection: consequences and opportunities. Front Oncol (2013) 0.86
Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells. J Biol Chem (2002) 0.85
N-cyclic bay-substituted perylene G-quadruplex ligands have selective antiproliferative effects on cancer cells and induce telomere damage. J Med Chem (2011) 0.84
Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas. Carcinogenesis (2013) 0.79
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib. Biochem Pharmacol (2015) 0.81
Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model. J Exp Clin Cancer Res (2015) 0.78
Targeting G-Quadruplex DNA Structures by EMICORON Has a Strong Antitumor Efficacy against Advanced Models of Human Colon Cancer. Mol Cancer Ther (2015) 0.76
Anacardic acid and thyroid hormone enhance cardiomyocytes production from undifferentiated mouse ES cells along functionally distinct pathways. Endocrine (2015) 0.75